6 weeks!
Dear Sean,
I am replying on behalf of Peter French to your email below.
Benitec can advise that it expects to report data from Cohort three patients in Q4 CY2015 following completion of all patient dosing and monitoring for the cohort, in line with timelines previously advised to the market.
Kind Regards,
Annabel Murphy